Narwhal Capital Management Gilead Sciences, Inc. Transaction History

Narwhal Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $225,112 - $283,040	-3,625 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $291,891 - $338,940	-4,035 Reduced 52.68%	3,625 $279,000
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $227,033 - $290,797	3,625 Added 89.84%	7,660 $573,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $1.49 Million - $1.65 Million	-23,900 Reduced 85.56%	4,035 $256,000
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $781,108 - $875,922	-12,625 Reduced 31.13%	27,935 $1.89 Million
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $100,985 - $113,130	-1,615 Reduced 3.83%	40,560 $2.64 Million
Q4 2018 Jan 15, 2019	BUY	$60.54 - $79.0 $237,922 - $310,470	3,930 Added 10.28%	42,175 $2.64 Million
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $334,659 - $370,529	4,695 Added 13.99%	38,245 $2.95 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $87,588 - $102,168	-1,350 Reduced 3.87%	33,550 $2.38 Million
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $539,744 - $658,008	-7,410 Reduced 17.51%	34,900 $2.63 Million
Q4 2017 Jan 23, 2018	BUY	$71.15 - $83.52 $212,027 - $248,889	2,980 Added 7.58%	42,310 $3.03 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.84 Million - $3.36 Million	39,330	39,330 $3.19 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

Stay updated on Narwhal Capital Management with notifications on news.